AK3280 not checked
Shanghai Ark Biopharmaceutical Co., Ltd. · AK3287
FollowEvery change as it happens, and a Monday email
Trials
1 active
5 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Participants will receive AK3280 400 mg twice daily, within 30 minutes after breakfast and dinner, with breakfast and dinner approximately 12 hours apart.”In the company’s words, NCT07719023 on ClinicalTrials.gov
- Tested for
- Idiopathic Pulmonary Fibrosis (IPF)
- Main trialPhase 3
- “This is a phase 3 clinical study conducted in China. The primary objective is to compare the efficacy and safety of AK3280 400 mg versus placebo and active control (pirfenidone) in IPF patients.”In the company’s words, NCT07719023 on ClinicalTrials.gov
- Other names
- AK3287
Other drugs for Idiopathic Pulmonary Fibrosis (IPF)
- SC1011JOYO Pharma · Phase 2/3
- NerandomilastBoehringer Ingelheim · Phase 3
- NAL ERTrevi Therapeutics · Phase 3
- TDI01Beijing Tide Pharmaceutical Co., Ltd · Phase 3
- INS018_055InSilico Medicine Hong Kong Limited · Phase 3
- AdmilparantBristol Myers Squibb · Phase 3
Coming up1
- 30 Sep 2028Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Not yet recruiting | 30 Sep 2028 | A Phase 3 Study of Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis | |
| Phase 2Unknown | Jul 2024 | A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis | |
| Phase 1/2Completed | 18 Jul 2023 | A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar | |
| Phase 1Completed | 9 Sep 2020 | A Study to Assess the Effect of AK3280 on Renal Function in Healthy Subjects | |
| Phase 1Completed | 28 Sep 2021 | A Study of AK3280 in Chinese Healthy Volunteers |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026